SCHEMBL7062860

SCHEMBL7062860

CC(C)(O[PH](=O)O)C(=O)C=Cc1cc(C(C)(C)C)c(O)c(C(C)(C)C)c1

nearest known ligand 0.55

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
GABBR2 O75899 2/20 0.55
GABBR1 Q9UBS5 2/20 0.55
GPR55 Q9Y2T6 1/20 0.46
TNFRSF1A P19438 1/20 0.44
PTGS1 P23219 4/20 0.43
PTGS2 P35354 4/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
EGFR P00533 1/20 0.41
ALOX5 P09917 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
HTT P42858 1/20 0.40
EEF2K O00418 1/20 0.39
SRC P12931 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Butane SCHEMBL7061276 0.95 GABBR2 (0.50) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL7062862 0.90 GABBR2 (0.56) GABBR2GABBR1GPR55TNFRSF1APTGS1
Butane SCHEMBL9226632 0.86 GABBR2 (0.47) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL10001168 0.79 GABBR2 (0.68) GABBR2GABBR1GPR55TNFRSF1APTGS1
Butane SCHEMBL5669981 0.78 HMGCR (0.37) GABBR2GABBR1CYP1A2CYP2C9ALOX5
Butane SCHEMBL5671319 0.78 NR5A2 (0.38) GABBR2GABBR1GPR55TNFRSF1APTGS2
SCHEMBL6910728 0.77 GABBR2 (0.54) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL6910438 0.77 GABBR2 (0.60) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL6910765 0.76 GABBR2 (0.52) GABBR2GABBR1GPR55TNFRSF1APTGS1
SCHEMBL9657108 0.75 GABBR2 (0.72) GABBR2GABBR1GPR55TNFRSF1APTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004026245-A2 SUBSTITUTED PHOSPHONATE COMPOUNDS HAVING BONE ANABOLIC ACTIVITY ILEX ONCOLOGY RESEARCH, SARL (CH) 2004-04-01 WO disclosed